Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2023-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains details about the meeting, the agenda items (such as approval of financial statements and director/auditor compensation), and the proxy solicitation process. This falls under the category of Proxy Solicitation & Information Statement.
2023-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Jeil Bio. It outlines the date, location, and agenda items (financial statement approval, director/auditor remuneration limits) for the upcoming Annual General Meeting. This document serves as the official notification and proxy-related information for shareholders to attend and vote, fitting the definition of Proxy Solicitation & Information Statement.
2023-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Cheilbio Co., Ltd. It outlines the meeting agenda, including the approval of financial statements, director remuneration, and auditor remuneration. It also contains supplementary information such as director activity reports, major shareholder transaction details, and business overviews, which are standard components of proxy materials provided to shareholders to inform their voting decisions. As it is a document sent to shareholders to request votes and provide necessary information for an upcoming meeting, it is classified as a Proxy Solicitation & Information Statement.
2023-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Jeil Bio) announcing a significant change in financial structure (revenue or profit/loss fluctuation of 30% or more). This is a standard regulatory disclosure required by the Korea Exchange (KRX) for listed companies to report material financial changes before the final audit report is finalized. It fits the definition of a regulatory filing (RNS) as it is a specific disclosure of financial performance highlights rather than a full annual report or an earnings release announcement. FY 2022
2023-02-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the procedural steps for the upcoming meeting. Given its nature as a regulatory notification regarding meeting logistics, it fits best under the RNS category.
2022-12-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '제일바이오' (Cheilbio Co., Ltd.) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business descriptions, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.